메뉴 건너뛰기
Circulation
Volumn 111, Issue 22, 2005, Pages
Letter regarding article by Devereux et al, "Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial"
Author keywords

[No Author keywords available]
Indexed keywords

ANTIHYPERTENSIVE AGENT; ATENOLOL; LOSARTAN;
EID: 33644796286     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.104.525519     Document Type: Letter
Times cited : (3)
References (5)
  • 1
    • 4544269713 scopus 로고    scopus 로고
    • Regression of hypertensive left ventricular hypertrophy by Losartan compared with atenolol: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial
    • DOI 10.1161/01.CIR.0000141573.44737.5A
    • Devereux RB, Dahlof B, Gerdts E, Boman K, Nieminen MS, Papademetriou V, Rokkedal J, Harris KE, Edelman JM, Wachtell K. Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial. Circulation. 2004;110:1456-1462. (Pubitemid 39238023)
    • (2004) Circulation , vol.110 , Issue.11 , pp. 1456-1462
    • Devereux, R.B.1    Dahlof, B.2    Gerdts, E.3    Boman, K.4    Nieminen, M.S.5    Papademetriou, V.6    Rokkedal, J.7    Harris, K.E.8    Edelman, J.M.9    Wachtell, K.10
  • 2
    • 17144409806 scopus 로고    scopus 로고
    • Benefits from angiotensin-converting enzyme inhibitor 'beyond blood pressure lowering': Beyond blood pressure or beyond the brachial artery?
    • Hirata K, Vlachopoulos C, Adji A, O'Rourke MF. Benefits from angiotensin-converting enzyme inhibitor "beyond blood pressure lowering": beyond blood pressure or beyond the brachial artery [published correction appears in J Hypertens. 2005;23:905-906]. J Hypertens. 2005;23:551-556. (Pubitemid 40684713)
    • (2005) Journal of Hypertension , vol.23 , Issue.3 , pp. 551-556
    • Hirata, K.1    Vlachopoulos, C.2    Adji, A.3    O'Rourke, M.F.4
  • 3
    • 0036107250 scopus 로고    scopus 로고
    • Reduction in arterial stiffness with angiotensin II antagonist is comparable with and additive to ACE inhibition
    • DOI 10.1016/S0895-7061(01)02313-5, PII S0895706101023135
    • Mahmud A, Feely J. Reduction in arterial stiffness with angiotensin II antagonist is comparable with and additive to ACE inhibition. Am J Hypertens. 2002;15:321-325. (Pubitemid 34408971)
    • (2002) American Journal of Hypertension , vol.15 , Issue.4 I , pp. 321-325
    • Mahmud, A.1    Feely, J.2
  • 4
    • 3843146120 scopus 로고    scopus 로고
    • Selective reduction of cardiac mass and central blood pressure on low-dose combination perindopril/indapamide in hypertensive subjects
    • DOI 10.1097/01.hjh.0000125448.28861.fc
    • de Luca N, Asmar RG, London GM, O'Rourke MF, Safar ME; REASON Project Investigators. Selective reduction of cardiac mass and central blood pressure on low-dose combination perindopril/indapamide in hypertensive subjects. J Hypertens. 2004;22:1623-1630. (Pubitemid 39037615)
    • (2004) Journal of Hypertension , vol.22 , Issue.8 , pp. 1623-1630
    • De Luca, N.1    Asmar, R.G.2    London, G.M.3    O'Rourke, M.F.4    Safar, M.E.5
  • 5
    • 0034688194 scopus 로고    scopus 로고
    • Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
    • The Heart Outcomes Prevention Evaluation Study Investigators
    • Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000;342:145-153.
    • (2000) N Engl J Med , vol.342 , pp. 145-153
    • Yusuf, S.1    Sleight, P.2    Pogue, J.3    Bosch, J.4    Davies, R.5    Dagenais, G.6

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.